Every finding on record at Ohio Living Holdings

Emergency Preparedness Survey At the time of the emergency preparedness survey completed 09/29/22, Ohio Living Home Health Greater Akron is in compliance with the provisions of 42 CFR Part 484.102, Conditions of Participation for Home Health Agencies.

Partial Extended Recertification Survey An entrance conference was conducted on 09/26/22 at 8:28 AM with administrative staff, and an exit conference was conducted on 09/29/22 at 1:01 PM with administrative staff. The following deficiency is based on the partial extended recertification survey completed 09/29/22. Ohio Living Home Health Greater Akron 367547, is not in compliance with the requirements found at 42 CFR Part 484, Subpart B, C for Home Health Agencies.

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on observation, record review, policy review and family and staff interviews, the agency failed to conduct a review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy for two of seven patients selected for home visit medication reviews (Patient #8 and #9). The total sample was 17. The census was 152. Findings include: Review of the agency policy titled, "Medication Profile," effective 03/25/14, revealed patients receiving medications will have a current, accurate medication profile in the medical record. Medication profiles will be updated for each change to reflect current medications, new and/or discontinued medications. 1. On 09/26/22 at 2:00 PM a home visit was made for Patient #8 with Staff B present. Observation of the medications Patient #8 was taking in the home revealed a bottle labeled Furosemide (water pill) 40 milligrams (mg) every day, filled on 08/31/22. Review of the current medication profile revealed and order for Furosemide 20 mg every day. The current medication profile flisted Metoprolol Tartrate (for high blood pressure) 50 mg one tablet taken twice a day. Interview on 09/26/22 at 2:10 PM with the patient's family member revealed this medication was changed after the last hospitalization at the end of August. The patient's start of care was 09/06/22. The family member also stated stated the Metoprolol Tartrate was discontinued at a doctor's appointment on 09/15/22. Staff B confirmed these findings in an interview on 09/26/22 at 2:17 PM. 2. On 09/26/22 at 12:30 PM a home visit was made for Patient #9 with Staff C present. Observation of the medications Patient #9 was taking in the home revealed a bottle labeled Carvedilol (for high blood pressure) 12.5 mg take one tablet twice a day. This was filled on 09/21/22. Review of the current medication profile for Patient #9 revealed orders for Carvedilol 25 mg take one tablet twice a day. Further review of the current medication profile for Patient #9 revealed an order for Lisinopril (for blood pressure) 20 mg two tablets daily. Interview with the patient's family member on 09/26/22 at 12:35 PM revealed the Lisinopril had been discontinued on 09/02/22. Interview with Staff C on 09/26/22 at 12:47 PM revealed the medication profile was not changed at the last home visit on 09/20/22. Further observation of the medications Patient #9 was taking in the home revealed Preser-Vision and Vitamin B12. Interview with the patient's family member on 09/26/22 at 12:52 PM revealed the patient had been taking these over-the-counter medications before being admitted to the agency on 08/23/22. Interview with Staff C on 09/26/22 at 12:59 PM confirmed these medications were not listed on the current medication profile.